secwatch.observer — SEC 8-K summary
======================================

Issuer:     Organogenesis Holdings Inc. (ORGO)
CIK:        0001661181
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0000950170-23-005554
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organogenesis Q4 revenue down 10% YoY; FY2023 guidance flat to +2%
------------------------------------------------------------------

- Q4 2022 net revenue $115.5M (-10% YoY); net income $7.5M vs $51.0M in Q4 2021.
- FY2022 net revenue $450.9M (-4% YoY); net income $15.5M vs $94.2M in FY2021.
- FY2023 guidance: revenue $450-462M (flat to +2%); net income $7.2-13.9M.
- PuraPly revenue expected to decline 18-26% in FY2023 to $180-200M.
- Adjusted EBITDA FY2023 guidance $36.5-46.0M vs $49.3M in FY2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661181/000095017023005554/0000950170-23-005554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661181/000095017023005554/orgo-20230301.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-005554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer